Evidence and support

Placenta capsules have no established benefit and infection risk

No robust mood benefit in the pilot; contaminated capsules were implicated in recurrent infant infection.

Research preview · selected sources rechecked September 14, 2026 · independent clinical review pending. These editorial assessments are not formal GRADE ratings. No study here establishes an effect of Brighter Postpartum.

avoid prevention · C20

Placenta capsules have no established benefit and infection risk

Population and setting: Small placebo-controlled pilot and CDC infant GBS investigation.
What was found: No robust mood benefit in the pilot; contaminated capsules were implicated in recurrent infant infection.
Limits and applicability: CDC advises avoiding placenta ingestion. Natural origin does not make a preparation safe.

Sources: S31 · S32 · Evidence record ↗

Interpretation boundary

Prevention, treatment, comfort, mechanism and research status are separate questions. Read the original source and retain its population, timing and limitations. This is not a personalized recommendation or a claim that our support program has this effect.

Version 1. Independent clinical review pending. Explore the connected evidence.